Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 9.27%24.08M | 6.04%274.72M | --22.04M | 6.51%259.09M | 20.58%243.26M | 25.51%106.26M | -2.57%201.74M | --84.67M | 20.13%207.07M | 38.41%172.38M |
| Operating income | 9.27%24.08M | 6.04%274.72M | 22.04M | 6.51%259.09M | 20.58%243.26M | 25.51%106.26M | -2.57%201.74M | 84.67M | 20.13%207.07M | 38.41%172.38M |
| Cost of sales | -22.44%-17.4M | -18.72%-206.15M | ---14.21M | -25.26%-173.65M | -34.77%-138.62M | -39.45%-63.72M | 21.90%-102.86M | ---45.7M | -32.85%-131.7M | -21.23%-99.14M |
| Operating expenses | -22.44%-17.4M | -18.72%-206.15M | -14.21M | -25.26%-173.65M | -34.77%-138.62M | -39.45%-63.72M | 21.90%-102.86M | -45.7M | -32.85%-131.7M | -21.23%-99.14M |
| Gross profit | -14.64%6.68M | -19.74%68.57M | 7.83M | -18.34%85.44M | 5.82%104.63M | 9.16%42.54M | 31.19%98.88M | 38.97M | 2.91%75.37M | 71.23%73.24M |
| Selling expenses | -54.54%-3.76M | 9.10%-6.46M | ---2.43M | -4.10%-7.11M | 13.87%-6.83M | 16.85%-5.03M | -71.12%-7.93M | ---6.05M | -64.12%-4.63M | -55.28%-2.82M |
| Administrative expenses | -6.11%-13.99M | 38.71%-25.57M | ---13.18M | -70.77%-41.71M | 5.33%-24.43M | 3.04%-23.19M | -30.43%-25.8M | ---23.92M | -28.51%-19.78M | -58.23%-15.39M |
| Research and development expenses | 43.08%-855K | -3.32%-6.23M | ---1.5M | -4.82%-6.03M | 16.25%-5.75M | -48.41%-4.67M | -2.92%-6.86M | ---3.15M | 3.56%-6.67M | -23.02%-6.91M |
| Impairment and provision | 200.27%4.16M | -2,065.71%-24.71M | ---4.15M | 119.67%1.26M | ---6.39M | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 200.27%4.16M | -2,065.71%-24.71M | ---4.15M | 119.67%1.26M | ---6.39M | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 351.33%6.63M | 5.48%6.05M | --1.47M | 44.91%5.73M | -18.27%3.96M | -12.84%3.22M | -5.67%4.84M | --3.7M | 367.21%5.13M | 29.79%1.1M |
| Operating profit | 90.58%-1.13M | -68.99%11.66M | -11.97M | -42.35%37.58M | 3.27%65.19M | 34.73%12.87M | 27.73%63.13M | 9.55M | 0.43%49.42M | 86.02%49.21M |
| Financing cost | -33.62%-7.5M | -15.24%-12.08M | ---5.62M | -17.71%-10.48M | -8.89%-8.91M | -4.71%-6.4M | -48.35%-8.18M | ---6.11M | -276.90%-5.51M | -95.85%-1.46M |
| Share of profits of associates | ---- | ---- | ---- | ---- | 32.82%-88K | ---- | -114.10%-131K | ---130K | --929K | ---- |
| Share of profit from joint venture company | -160.29%-1.08M | -562.15%-1.33M | ---413K | --288K | ---- | 25.97%-57K | ---33K | ---77K | ---- | ---- |
| Earning before tax | 46.07%-9.71M | -106.42%-1.76M | -17.99M | -51.27%27.39M | 2.58%56.2M | 98.39%6.41M | 22.19%54.78M | 3.23M | -6.10%44.83M | 85.74%47.75M |
| Tax | -132.78%-971K | 139.40%1.87M | --2.96M | 33.64%-4.74M | 15.97%-7.14M | 110.82%120K | -57.49%-8.5M | ---1.11M | -6.18%-5.4M | -70.02%-5.08M |
| After-tax profit from continuing operations | 28.98%-10.68M | -99.51%110K | -15.03M | -53.83%22.65M | 5.99%49.06M | 207.68%6.53M | 17.36%46.28M | 2.12M | -7.56%39.44M | 87.81%42.66M |
| Earning after tax | 28.98%-10.68M | -99.51%110K | -15.03M | -53.83%22.65M | 5.99%49.06M | 207.68%6.53M | 17.36%46.28M | 2.12M | -7.56%39.44M | 87.81%42.66M |
| Minority profit | 6.43%-131K | -38.03%-323K | ---140K | -182.98%-234K | -7.54%282K | -63.77%146K | --305K | --403K | ---- | ---- |
| Profit attributable to shareholders | 29.19%-10.55M | -98.11%433K | -14.89M | -53.09%22.88M | 6.08%48.77M | 271.28%6.39M | 16.58%45.98M | 1.72M | -7.56%39.44M | 87.81%42.66M |
| Basic earnings per share | 33.33%-0.02 | -98.42%0.0009 | -0.03 | -56.31%0.0568 | -100.00%0.13 | 1K | 16.75%4.6K | -99.99%3.94K | 42.66M | |
| Diluted earnings per share | 33.33%-0.02 | -98.42%0.0009 | -0.03 | -56.31%0.0568 | -100.00%0.13 | 1K | 16.75%4.6K | -99.99%3.94K | 42.66M | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | KPMG | -- | PwC accounting firm | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.